Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

Candidates for NJ governor are using AI in their ads in new ways

Even with the use of AI disclosed in ads, experts question the ethics of using the technology in campaigns designed to reach voters. Candidates for New Jersey governor on both sides of the aisle are pushing the envelope with the use of artificial intelligence in their...

Smart weighs in on possible NJ Transit rail strike

As talks continue between #NJTransit and its rail engineers' union to try to avert a walkout by the union at midnight on Thursday, professor Mike Smart weighed in on the looming issues with the WABC7 Eyewitness News Mornings @ 10 team.

NJSPL: Snapshot of NJ Undergrad Degree Earners

Snapshot of Undergraduate Degree Earners in New Jersey New Jersey State Policy Lab, Angie Nga Le The National Student Clearing House Research Center has released a new Undergraduate Degree Earners report covering the 2023-2024 academic year[1]. According to the...

First-Generation Rutgers Alumni National Leaders in Senior Care

Sam Starnes GSN'04 for Rutgers Today, May 12, 2025 Phil Scalo and Roberto Muñiz influence with compassion the care of millions in nursing homes, assisted-living facilities, and affordable housing for seniors, as well as others in need of aging services. Phil Scalo...

NJSPL Report: Emotional Well-Being of NJ Nurses

Report Release: Emotional Well-Being of New Jersey Nurses Post-COVID-19 New Jersey State Policy Lab COVID-19 brought to light the disparities among the nursing workforce that have been simmering in our health care system and highlighted the need for nurses to access...